Ageing – Pipeline Insight, 2019

33

Summary

• Provides an overview of therapeutic pipeline activity for Ageing across the complete product development cycle including all clinical and non-clinical stages

Press Release

“Ageing – Pipeline Insight, 2019” report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Ageing. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type.
Products covered by Phase
• Phase III, Phase II, Phase I
• Pre-clinical & Discovery
• Inactive (Discontinued and Dormant) Overview of pipeline development activities for Ageing Pipeline analysis of therapeutic drugs include but are not limited to drug description and development activities focusing on clinical and pre-clinical results, designations, collaborations & licensing deals, grants, technology and patent details. Therapeutic segmentation of products for Ageing The report comprises of comparative pipeline therapeutics assessment by development stage, therapy type, molecule type, and administration route across this indication.
Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.